{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:17Z","timestamp":1789628537687,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K08514, 23659477, 21K20933, and 22K16396"],"award-info":[{"award-number":["18K08514, 23659477, 21K20933, and 22K16396"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17bm0804012h0001"],"award-info":[{"award-number":["17bm0804012h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-63183-x","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T06:48:22Z","timestamp":1756104502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-9857","authenticated-orcid":false,"given":"Keitaro","family":"Kanie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genzo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-5326","authenticated-orcid":false,"given":"Ryusaku","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3149-4408","authenticated-orcid":false,"given":"Keiko","family":"Muguruma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-232X","authenticated-orcid":false,"given":"Shin","family":"Urai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-2714","authenticated-orcid":false,"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-653X","authenticated-orcid":false,"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-4366","authenticated-orcid":false,"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2291-4586","authenticated-orcid":false,"given":"Shin","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-9246","authenticated-orcid":false,"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"63183_CR1","doi-asserted-by":"publisher","first-page":"bnz003","DOI":"10.1210\/endrev\/bnz003","volume":"41","author":"M Yamamoto","year":"2020","unstructured":"Yamamoto, M. et al. Autoimmune pituitary disease: new concepts with clinical implications. Endocr. Rev. 41, bnz003 (2020).","journal-title":"Endocr. Rev."},{"key":"63183_CR2","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/EJE-19-1051","volume":"182","author":"Y Takahashi","year":"2020","unstructured":"Takahashi, Y. Mechanisms in endocrinology: autoimmune hypopituitarism: novel mechanistic insights. Eur. J. Endocrinol. 182, R59\u2013r66 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"63183_CR3","doi-asserted-by":"publisher","first-page":"101601","DOI":"10.1016\/j.beem.2021.101601","volume":"36","author":"H Bando","year":"2021","unstructured":"Bando, H. et al. Paraneoplastic autoimmune hypophysitis: an emerging concept. Best. Pract. Res. Clin. Endocrinol. Metab. 36, 101601 (2021).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"63183_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1172\/JCI44073","volume":"121","author":"M Yamamoto","year":"2011","unstructured":"Yamamoto, M. et al. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J. Clin. Invest. 121, 113\u2013119 (2011).","journal-title":"J. Clin. Invest."},{"key":"63183_CR5","doi-asserted-by":"publisher","first-page":"E1744","DOI":"10.1210\/jc.2014-1769","volume":"99","author":"H Bando","year":"2014","unstructured":"Bando, H. et al. Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome. J. Clin. Endocrinol. Metab. 99, E1744\u2013E1749 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"63183_CR6","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1210\/js.2019-00243","volume":"3","author":"K Kanie","year":"2019","unstructured":"Kanie, K. et al. Pathogenesis of anti-PIT-1 antibody syndrome: PIT-1 presentation by HLA class I on anterior pituitary cells. J. Endocr. Soc. 3, 1969\u20131978 (2019).","journal-title":"J. Endocr. Soc."},{"key":"63183_CR7","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1210\/en.2007-1692","volume":"149","author":"SC Tzou","year":"2008","unstructured":"Tzou, S. C. et al. Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 149, 3461\u20133469 (2008).","journal-title":"Endocrinology"},{"key":"63183_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep43492","volume":"7","author":"HH Lin","year":"2017","unstructured":"Lin, H. H. et al. In situ activation of pituitary-infiltrating T lymphocytes in autoimmune hypophysitis. Sci. Rep. 7, 43492 (2017).","journal-title":"Sci. Rep."},{"key":"63183_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/08916934.2002.11873703","volume":"33","author":"K Watanabe","year":"2001","unstructured":"Watanabe, K. et al. Characteristics of experimental autoimmune hypophysitis in rats: major antigens are growth hormone, thyrotropin, and luteinizing hormone in this model. Autoimmunity 33, 265\u2013274 (2001).","journal-title":"Autoimmunity"},{"key":"63183_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/07435808209045760","volume":"9","author":"I Klein","year":"1982","unstructured":"Klein, I., Kraus, K. E., Martines, A. J. & Weber, S. Evidence for cellular mediated immunity in an animal model of autoimmune pituitary disease. Endocr. Res. Commun. 9, 145\u2013153 (1982).","journal-title":"Endocr. Res. Commun."},{"key":"63183_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","volume":"16","author":"JE Young","year":"2015","unstructured":"Young, J. E. et al. Elucidating molecular phenotypes caused by the SORL1 Alzheimer\u2019s disease genetic risk factor using human induced pluripotent stem cells. Cell. Stem Cell. 16, 373\u2013385 (2015).","journal-title":"Cell. Stem Cell."},{"key":"63183_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1172\/JCI127378","volume":"130","author":"R Matsumoto","year":"2020","unstructured":"Matsumoto, R. et al. Congenital pituitary hypoplasia model demonstrates hypothalamic OTX2 regulation of pituitary progenitor cells. J. Clin. Investig. 130, 641\u2013654 (2020).","journal-title":"J. Clin. Investig."},{"key":"63183_CR13","doi-asserted-by":"publisher","first-page":"107894","DOI":"10.1016\/j.celrep.2020.107894","volume":"32","author":"NC Leite","year":"2020","unstructured":"Leite, N. C. et al. Modeling Type 1 diabetes in vitro using human pluripotent stem cells. Cell Rep. 32, 107894 (2020).","journal-title":"Cell Rep."},{"key":"63183_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08774-1","volume":"10","author":"NW Pedersen","year":"2019","unstructured":"Pedersen, N. W. et al. CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat. Commun. 10, 837 (2019).","journal-title":"Nat. Commun."},{"key":"63183_CR15","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1093\/ejendo\/lvad179","volume":"190","author":"S Urai","year":"2024","unstructured":"Urai, S. et al. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition. Eur. J. Endocrinol. 190, K1\u2013k7 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"63183_CR16","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","volume":"110","author":"D Sugiyama","year":"2013","unstructured":"Sugiyama, D. et al. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc. Natl Acad. Sci. USA 110, 17945\u201317950 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63183_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"63183_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409\u2013412 (2011).","journal-title":"Nat. Methods"},{"key":"63183_CR19","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.celrep.2016.10.026","volume":"17","author":"Y Ishida","year":"2016","unstructured":"Ishida, Y. et al. Vulnerability of Purkinje cells generated from spinocerebellar ataxia type 6 patient-derived iPSCs. Cell Rep. 17, 1482\u20131490 (2016).","journal-title":"Cell Rep."},{"key":"63183_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10351","volume":"7","author":"C Ozone","year":"2016","unstructured":"Ozone, C. et al. Functional anterior pituitary generated in self-organizing culture of human embryonic stem cells. Nat. Commun. 7, 10351 (2016).","journal-title":"Nat. Commun."},{"key":"63183_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature10637","volume":"480","author":"H Suga","year":"2011","unstructured":"Suga, H. et al. Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480, 57\u201362 (2011).","journal-title":"Nature"},{"key":"63183_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","volume":"29","author":"M Jin","year":"2022","unstructured":"Jin, M. et al. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer\u2019s disease. Cell. Stem Cell. 29, 1135\u20131153.e8 (2022).","journal-title":"Cell. Stem Cell."},{"key":"63183_CR23","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1182\/blood-2003-11-4025","volume":"103","author":"MP Crawford","year":"2004","unstructured":"Crawford, M. P. et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103, 4222\u20134231 (2004).","journal-title":"Blood"},{"key":"63183_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63\u201368 (2018).","journal-title":"Nature"},{"key":"63183_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep43060","volume":"7","author":"H Bando","year":"2017","unstructured":"Bando, H. et al. A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome. Sci. Rep. 7, 43060 (2017).","journal-title":"Sci. Rep."},{"key":"63183_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41574-025-01099-8","volume":"21","author":"S Urai","year":"2025","unstructured":"Urai, S. et al. Anti-PIT1 hypophysitis after immune checkpoint inhibitor treatment. Nat. Rev. Endocrinol. 21, 265\u2013266 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"63183_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature06406","volume":"450","author":"S Nejentsev","year":"2007","unstructured":"Nejentsev, S. et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450, 887\u2013892 (2007).","journal-title":"Nature"},{"key":"63183_CR28","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.1710415114","volume":"114","author":"S Tan","year":"2017","unstructured":"Tan, S. et al. Type 1 diabetes induction in humanized mice. Proc. Natl Acad. Sci. USA 114, 10954\u201310959 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63183_CR29","doi-asserted-by":"crossref","unstructured":"Miyazaki Y. et al. Development of a novel redirected T cell\u2013based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T cell leukemia. Blood. 121, 4894\u20134901 (2013).","DOI":"10.1182\/blood-2012-11-465971"},{"key":"63183_CR30","doi-asserted-by":"publisher","first-page":"11796","DOI":"10.1073\/pnas.0803078105","volume":"105","author":"T Wataya","year":"2008","unstructured":"Wataya, T. et al. Minimization of exogenous signals in ES cell culture induces rostral hypothalamic differentiation. Proc. Natl Acad. Sci. USA 105, 11796\u201311801 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63183_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12865-016-0177-5","volume":"17","author":"K Kitaura","year":"2016","unstructured":"Kitaura, K. et al. A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) \u03b1 and \u03b2 repertoires and identifying potential new invariant TCR \u03b1 chains. BMC Immunol. 17, 38 (2016).","journal-title":"BMC Immunol."},{"key":"63183_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fimmu.2017.00389","volume":"8","author":"K Kitaura","year":"2017","unstructured":"Kitaura, K. et al. Different somatic hypermutation levels among antibody subclasses disclosed by a new next-generation sequencing-based antibody repertoire analysis. Front Immunol. 8, 389 (2017).","journal-title":"Front Immunol."},{"key":"63183_CR33","doi-asserted-by":"publisher","unstructured":"Kanie, K. Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-induced organoid. figshare https:\/\/doi.org\/10.6084\/m9.figshare.24320965 (2025).","DOI":"10.6084\/m9.figshare.24320965"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63183-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:11:23Z","timestamp":1757455883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63183-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63183"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63183-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yutaka Takahashi has received research funding from Teijin Pharma Co., Ltd. and Ono Pharma Co., Ltd. Shin Kaneko is a founder, shareholder, and director of Thyas Co., Ltd. and has received research funding from Takeda Pharmaceutical Co., Ltd., Astellas Co., Ltd., Kirin Co., Ltd., Terumo Co., Ltd., and Thyas Co., Ltd. The other authors have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7900"}}